Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,208 | 100,554 | 85,873 | 22,938 | 30,226 |
| Marketable Securities | 163,903 | 61,959 | 17,239 | 235,837 | 49,773 |
| Receivables | 744 | 815 | 568 | 1,763 | 1,186 |
| TOTAL | $214,738 | $169,684 | $109,167 | $264,650 | $85,552 |
| Non-Current Assets | |||||
| PPE Net | 53,427 | 58,754 | 65,087 | 70,829 | 78,192 |
| Investments And Advances | 0 | 0 | 55,686 | 0 | 0 |
| Intangibles | 98,100 | 25,798 | 25,798 | 25,798 | 25,798 |
| Other Non-Current Assets | 619 | 3,525 | 5,770 | 8,019 | 724 |
| TOTAL | $152,146 | $88,077 | $152,341 | $104,646 | $104,714 |
| Total Assets | $366,884 | $257,761 | $261,508 | $369,296 | $190,266 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,138 | 38,482 | 963 | 880 | 816 |
| Accounts payable and accrued liabilities | 3,159 | 5,919 | 7,926 | 7,344 | 6,513 |
| Accrued Expenses | 6,264 | 5,611 | 6,615 | 9,093 | 7,325 |
| TOTAL | $10,775 | $50,954 | $21,176 | $35,347 | $45,966 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,345 | 28,482 | 29,529 | 30,493 | 31,372 |
| Deferred Revenues | 214 | 942 | 5,672 | 18,030 | 31,312 |
| Other Non-Current Liabilities | 48,783 | 616 | 764 | 31,030 | 739 |
| TOTAL | $109,085 | $43,310 | $44,505 | $77,649 | $58,799 |
| Total Liabilities | $119,860 | $94,264 | $65,681 | $112,996 | $104,765 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,247 | 25,098 | 19,624 | 19,548 | 11,144 |
| Common Shares | 338 | 176 | 137 | 137 | 78 |
| Retained earnings | -673,406 | -570,175 | -487,395 | -410,535 | -351,741 |
| Other shareholders' equity | -232 | -378 | 10,247 | -4 | -16 |
| TOTAL | $247,024 | $163,497 | $195,827 | $256,300 | $85,501 |
| Total Liabilities And Equity | $366,884 | $257,761 | $261,508 | $369,296 | $190,266 |